body~politic

Thursday, August 11, 2016

MIT Develops Single Dose Biopharm Machine - ValueWalk

MIT Develops Single Dose Biopharm Machine - ValueWalkThrough the use of a specific yeast and cells held in liquid, researchers from the Massachusetts Institute of Technology showed in a paper last week that their device could manufacture a single dose of biopharmaceuticals for doctors in remote areas or battlefields to administer to patients in need.



Twitter

-view CSL mobile version -



Webring Translator Thingamajig